Oral lichenoid eruption associated with imatinib treatment.
Gómez Fernández
Cristina
C
Sendagorta Cudós
Elena
E
Casado Verrier
Beatriz
B
Feito Rodríguez
Marta
M
Suárez Aguado
Judith
J
Vidaurrázaga Díaz de Arcaya
Carmen
C
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D017512:Lichenoid Eruptions / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D009059:Mouth Diseases / Q000139:chemically induced* / Q000473:pathology; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate